Inhibrx Biosciences, Inc. (INBX) Stock Price History
Historical prices from 2020 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
INBX Stock Price Trajectory (2020–2026)
As of February 28, 2026, Inhibrx Biosciences, Inc. (INBX) trades at $74.13, representing a +459.5% return over the past year. The stock has delivered a +20.7% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $94.57 on December 22, 2025. From this peak, INBX has corrected -21.6%, currently trading 57% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), INBX has outperformed the peer group average. Compare INBX vs RVMD →
Historical Price Data
Showing 30 of 1,388 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 77.23 | 78.48 | 73.42 | 74.13 | 74 | -4.01% |
| 2026-02-26 | 80.63 | 80.63 | 76.86 | 77.23 | 77 | -3.79% |
| 2026-02-25 | 80.15 | 82.59 | 78.88 | 80.27 | 80 | +0.97% |
| 2026-02-24 | 78.00 | 80.77 | 77.80 | 79.50 | 79 | +3.80% |
| 2026-02-23 | 79.84 | 80.11 | 76.03 | 76.59 | 76 | -2.61% |
| 2026-02-20 | 80.47 | 81.02 | 76.17 | 78.64 | 78 | -3.01% |
| 2026-02-19 | 80.58 | 84.50 | 80.47 | 81.08 | 105K | -0.61% |
| 2026-02-18 | 77.06 | 82.20 | 76.95 | 81.58 | 230K | +7.20% |
| 2026-02-17 | 75.00 | 76.82 | 75.00 | 76.10 | 5K | +0.40% |
| 2026-02-13 | 82.30 | 84.15 | 75.76 | 75.80 | 138K | -7.68% |
| 2026-02-12 | 82.90 | 83.84 | 79.36 | 82.11 | 110K | +0.15% |
| 2026-02-11 | 84.08 | 84.08 | 77.24 | 81.99 | 193K | -1.57% |
| 2026-02-10 | 86.94 | 86.94 | 82.08 | 83.30 | 139K | -3.69% |
| 2026-02-09 | 83.40 | 88.72 | 82.81 | 86.49 | 138K | +3.07% |
| 2026-02-06 | 83.22 | 84.98 | 81.35 | 83.91 | 143K | +2.92% |
| 2026-02-05 | 82.13 | 84.99 | 78.48 | 81.53 | 149K | -1.25% |
| 2026-02-04 | 85.19 | 86.17 | 80.51 | 82.56 | 171K | -2.96% |
| 2026-02-03 | 82.50 | 88.00 | 82.14 | 85.08 | 196K | +3.47% |
| 2026-02-02 | 76.04 | 84.05 | 76.04 | 82.23 | 203K | +7.81% |
| 2026-01-30 | 72.01 | 76.94 | 70.64 | 76.27 | 292K | +5.11% |
| 2026-01-29 | 74.74 | 75.25 | 72.40 | 72.56 | 296K | -1.92% |
| 2026-01-28 | 73.52 | 76.72 | 71.93 | 73.98 | 475K | +0.67% |
| 2026-01-27 | 72.00 | 74.00 | 71.62 | 73.49 | 147K | +2.07% |
| 2026-01-26 | 74.27 | 76.18 | 71.25 | 72.00 | 184K | -3.56% |
| 2026-01-24 | 79.62 | 79.62 | 74.66 | 74.66 | 122K | 0.00% |
| 2026-01-23 | 79.62 | 79.62 | 74.66 | 74.66 | 122K | -6.08% |
| 2026-01-22 | 75.17 | 82.16 | 75.17 | 79.49 | 304K | +5.85% |
| 2026-01-21 | 73.01 | 75.98 | 72.47 | 75.10 | 147K | +3.02% |
| 2026-01-20 | 71.75 | 75.58 | 70.60 | 72.90 | 234K | +0.87% |
| 2026-01-16 | 72.50 | 74.45 | 71.10 | 72.27 | 253K | +0.65% |
See INBX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INBX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare INBX vs AGIO
See how INBX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has INBX stock performed recently?
INBX returned +459.5% over the past year, beating its 5-year annualized CAGR of +20.7%. The stock trades above its 200-day moving average, confirming the uptrend.
What is INBX's all-time high price?
Inhibrx Biosciences, Inc. reached $94.56 on 2025-12-22. The 52-week high is $94.56. Current 1-year return of +459.5% places the stock closer to historical peaks.
Where can I download INBX historical price data?
This page provides INBX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.